News
September 23, 2025
AbTherx and Dragonfly Therapeutics Expand Antibody Discovery Partnership
Expansion comes after multi-target evaluation with Atlas™ Full Human Diversity Mice demonstrated superior performance in head-to-head study Mountain View, Calif. – Se... Read More »
September 17, 2025
AbTherx and Mosaic Biosciences Forge Exclusive Partnership to Provide Milestone-...
MOUNTAIN VIEW, Calif. and BOULDER, Colo. – September 17, 2025 – AbTherx and Mosaic Biosciences today announced a strategic agreement under which Mosaic will be the ex... Read More »
September 9, 2025
AbTherx Appoints Abhi Saharia, PhD, as Chief Business Officer
Seasoned biotech executive joins AbTherx to support expanding portfolio of biopharma partnerships MOUNTAIN VIEW, Calif. – September 9, 2025 – AbTherx, a biotechnology... Read More »
June 16, 2025
AbTherx and GPCR Therapeutics Announce a Strategic Collaboration to Discover...
Partnership combines AbTherx’s proprietary Atlas™ Long CDR3 Technology with GPCR Therapeutics’ deep expertise in GPCR biology to discover and develop antibodies for n... Read More »
June 10, 2025
AbTherx and Wield Therapeutics Partner to Advance New Antibody Therapies
AbTherx’s highly efficient research planning and partnering process enabled Wield, an early-stage startup, to achieve concept-to-collaboration within weeks Mountain V... Read More »
